260 related articles for article (PubMed ID: 25731329)
1. [A case of descending colon cancer with multiple liver metastases effectively treated with capecitabine/oxaliplatin (CapeOX) and bevacizumab].
Nakano M; Kameyama H; Shimada Y; Hashimoto Y; Hosoi M; Nakano M; Nogami H; Hanyu T; Takizawa K; Ishikawa T; Sakata J; Kobayashi T; Minagawa M; Kosugi S; Koyama Y; Wakai T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1785-7. PubMed ID: 25731329
[TBL] [Abstract][Full Text] [Related]
2. [Recurrent rectal cancer with multiple liver and lung metastases treated effectively with oxaliplatin and capecitabine plus bevacizumab chemotherapy-a case report].
Yabe N; Murai S; Shimizu H; Kitasato K; Yoshikawa T; Oto I; Nakadai J; Hasegawa H; Kitagawa Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1834-6. PubMed ID: 24393938
[TBL] [Abstract][Full Text] [Related]
3. [A Case of Colon Cancer with Multiple Liver Metastases Successfully Treated with Capecitabine/Oxaliplatin plus Bevacizumab].
Suematsu Y; Ishibashi Y; Hiratsuka M; Suda H; Takahashi M; Saito H; Omori K; Morita A; Wakabayashi K; Ito Y
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2100-2. PubMed ID: 26805277
[TBL] [Abstract][Full Text] [Related]
4. [A case of endocrine cell carcinoma of the ascending colon with liver metastasis treated with hepatectomy after excision of the primary lesion and systemic chemotherapy].
Yamanashi T; Nishi T; Yamamoto T; Toriumi F; Koshida Y; Mukai K; Shimoyama Y
Gan To Kagaku Ryoho; 2014 Jan; 41(1):107-12. PubMed ID: 24423963
[TBL] [Abstract][Full Text] [Related]
5. [A Case of Synchronous Multiple Liver Metastases from Ascending Colon Cancer Showing Pathological Complete Response to CapeOX Treatment].
Okugawa K; Ioka E; Ishikawa T; Takemoto M; Osaka M; Kadotani Y; Nakano K; Akioka K; Osaka Y; Tsuchiya K
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1913-1915. PubMed ID: 29394818
[TBL] [Abstract][Full Text] [Related]
6. Successful combination therapy of radical liver resection with 5-fluorouracil/leucovorin, oxaliplatin, plus bevacizumab for ascending colon cancer with pulmonary and 43 liver metastases: report of a case.
Ochiai T; Masuda T; Yagi M; Kasai R; Furuyama T; Tsukamoto K; Ito H; Igari K; Aihara A; Kumagai Y; Iida M; Odajima H; Tanaka S; Arii S; Yamazaki S
Int Surg; 2012; 97(1):6-13. PubMed ID: 23101994
[TBL] [Abstract][Full Text] [Related]
7. [Preoperative chemotherapy with modified FOLFOX + panitumumab for the treatment of descending colon cancer with multiple liver metastases - a case study].
Yagi Y; Yamazaki T; Iwaya A; Manabe S
Gan To Kagaku Ryoho; 2015 Jan; 42(1):109-12. PubMed ID: 25596691
[TBL] [Abstract][Full Text] [Related]
8. [A case of transverse colon cancer with multiple liver metastases and hepatic pedicle lymph node involvement showing pathological complete response by XELOX plus bevacizumab].
Mukai T; Akiyoshi T; Koga R; Arita J; Saiura A; Ikeda A; Nagasue Y; Oikawa Y; Yamakawa K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M; Suenaga M; Mizunuma N; Shinozaki E; Yamamoto C; Yamaguchi T
Gan To Kagaku Ryoho; 2012 Dec; 39(13):2561-3. PubMed ID: 23235180
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Hemodialysis Patients with Resected Synchronous Multiple Metastases from Colorectal Cancer Successfully Treated with CapeOX Therapy].
Yamagishi S; Suematsu Y; Takahashi M; Saito H; Nakayama M; Fukabori M; Morita A; Wakabayashi K; Itoh Y
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1767-1769. PubMed ID: 28133125
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Liver Metastasis of Descending Colon Cancer with a Pathological Complete Response to mFOLFOX6].
Kawamoto Y; Ome Y; Koda Y; Saga K; Kawamoto K; Ito T
Gan To Kagaku Ryoho; 2016 Jan; 43(1):125-8. PubMed ID: 26809540
[TBL] [Abstract][Full Text] [Related]
11. Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases. The MetaPan study.
Leone F; Artale S; Marino D; Cagnazzo C; Cascinu S; Pinto C; Fornarini G; Tampellini M; Di Fabio F; Sartore-Bianchi A; De Carlis L; Pugliese R; Capussotti L; Gioeni L; Siena S; Aglietta M
Cancer; 2013 Oct; 119(19):3429-35. PubMed ID: 23868516
[TBL] [Abstract][Full Text] [Related]
12. [A case of a recurrent hepatic metastasis occurred after curative resection of ascending colon cancer and a hepatic metastasis responding completely to capecitabine plus bevacizumab].
Murayama M; Kohno T; Miyazawa M; Shimazaki A; Miyaki A; Usuda A; Asaka S; Yamaguchi K; Yokomizo H; Shiozawa S; Yoshimatsu K; Shimakawa T; Katsube T; Naritaka Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2014-6. PubMed ID: 24393997
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant therapy of bevacizumab in combination with oxaliplatin and capecitabine (XELOX) for patients with metastatic colorectal cancer with unresectable liver metastases: a phase II, open-label, single-arm, noncomparative trial.
Chen HH; Lin JK; Chen JB; Chuang CH; Liu MC; Wang JY; Changchien CR
Asia Pac J Clin Oncol; 2018 Feb; 14(1):61-68. PubMed ID: 28906589
[TBL] [Abstract][Full Text] [Related]
14. Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer.
Gruenberger B; Tamandl D; Schueller J; Scheithauer W; Zielinski C; Herbst F; Gruenberger T
J Clin Oncol; 2008 Apr; 26(11):1830-5. PubMed ID: 18398148
[TBL] [Abstract][Full Text] [Related]
15. [Eighty-five-year-old patient with recurrent rectal cancer effectively treated with CapeOX chemotherapy].
Shimada Y; Sakamoto T; Oyamatsu M; Sato K; Tani T
Gan To Kagaku Ryoho; 2011 Jul; 38(7):1213-5. PubMed ID: 21772115
[TBL] [Abstract][Full Text] [Related]
16. [A Super-Elderly Patient with Recurrent Colon Cancer with Metastasis Effectively Treated with Capecitabine plus Bevacizumab Chemotherapy-A Case Report].
Matsui S; Kajiyama D; Kawaguchi M; Ohira K; Amagasa H; Noguchi T; Sugita H; Ganno H; Imai K; Ami K; Fukuda A; Ando M
Gan To Kagaku Ryoho; 2018 Dec; 45(13):1943-1945. PubMed ID: 30692405
[TBL] [Abstract][Full Text] [Related]
17. Practical use of capecitabine plus oxaliplatin (CAPEOX) with bevacizumab for patients with metastatic colorectal cancer that cannot expect conversion therapy.
Yokomizo H; Yoshimatsu K; Otani T; Osawa G; Nakayama M; Matsumoto A; Yano Y; Okayama S; Naritaka Y
Hepatogastroenterology; 2013; 60(128):1911-5. PubMed ID: 24719926
[TBL] [Abstract][Full Text] [Related]
18. [Systemic chemotherapy and surgery for recurrent metachronous liver metastases with peritoneal dissemination from triple colon cancers-a case report].
Kato T; Noda H; Watanabe F; Kakizawa N; Toyama N; Rikiyama T
Gan To Kagaku Ryoho; 2014 Dec; 41(13):2615-7. PubMed ID: 25596059
[TBL] [Abstract][Full Text] [Related]
19. 18FDG-PET evaluation correlates better than CT with pathological response in a metastatic colon cancer patient treated with bevacizumab-based therapy.
Funaioli C; Pinto C; Di Fabio F; Santini D; Ceccarelli C; De Raffaele E; Fanti S; Castellucci P; Longobardi C; Buggi F; Martoni AA
Tumori; 2007; 93(6):611-5. PubMed ID: 18338499
[TBL] [Abstract][Full Text] [Related]
20. [Retrospective analysis of the bevacizumab and CapeOX combination in untreated metastatic/recurrent colorectal cancer].
Miyamae Y; Takahashi K; Igarashi T; Tanaka K; Takahashi N; Hirai K; Tsukagoshi H; Ogawa H; Yoshinari D; Sunose Y; Takeyoshi I
Gan To Kagaku Ryoho; 2014 Jun; 41(6):737-41. PubMed ID: 25129085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
